NHLBI Withdraws Participation in PA-11-009, Translational Scholar Career Awards in Pharmacogenomics and Personalized Medicine (K23)

Notice Number: NOT-HL-11-132

Key Dates
Release Date: November 16, 201

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to notify potential applicants that NHLBI withdraws from participation in PA-11-009 “Translational Scholar Career Awards in Pharmacogenomics and Personalized Medicine (K23)”, http://grants.nih.gov/grants/guide/pa-files/PA-11-009.html, effective immediately.

The following institutes and centers will continue to participate in this FOA:

National Center for Research Resources (NCRR), (http://www.ncrr.nih.gov)
National Cancer Institute (NCI), (http://www.nci.nih.gov)
National Institute on Drug Abuse (NIDA), (http://www.nida.nih.gov)
National Institute of General Medical Sciences (NIGMS), (http://www.nigms.nih.gov)
National Institute of Nursing Research (NINR), (http://www.ninr.nih.gov)

All other aspects of this FOA remain unchanged.

Inquiries

Inquiries should be directed to:

Jane D. Scott, ScD, MSN, FAHA
Director, Office of Research Training and Career Development,
Division of Cardiovascular Sciences (DCVS), NHLBI, NIH
6701 Rockledge Drive
Bethesda, MD 20892-8902
Telephone: 301.435.0535; 301.402.5264
Fax 301.480.7404
scottj2@nhlbi.nih.gov